https://storage.googleapis.com/vendorgroup-assets/site/7d8d13ba-3099-4e93-91b3-6a7e3abc43b6/android-icon-192x192.png

Sign up for alerts

Fill out the form below to receive real-time email notifications for select financial press releases, and SEC filings.

Your privacy

At NovaBay, we value your privacy. We never share, rent, or loan any of your information to any third parties. Your data is kept secure and is only used in ways that you have given your consent to.

Analyst Coverage

Ascendiant Capital Markets

Edward Woo
+1 561 327 9435
ewoo@ascendiant.com

Ladenburg, Thalmann & Co.

Jeffrey S. Cohen
+1 646 634 2951
Jcohen@ladenburg.com

Destiny A. Hance
+1 646 634 9085
dbuch@ladenburg.com

Investor Contacts

The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC, with the following contact information:

For Standard U.S. Postal Mail

Equiniti Trust Company, LLC (“EQ”)
P.O. Box 500
Newark, NJ 07101

For Overnight / Express Delivery

Equiniti Trust Company, LLC (“EQ”)
55 Challenger Road, Floor 2
Ridgefield Park, NJ 07660

Telephone, Fax & Website

Toll Free in the US +1 800 937 5449
Foreign Shareowners: 718 921 8124
Email address: helpAST@equiniti.com
Website: https://equiniti.com

For Dwac Instructions Provided to Brokers

Transfer Agent Number – 2941

IRS Form 8937

IRS Form 8937 for May 2024 Reverse Stock Split

Company

NovaBay Pharmaceuticals, Inc.
NYSE AMEX: NBY
Russell Microcap Index component

IR Contact

LHA Investor Relations
Jody Cain
jcain@lhai.com
310-691-7100

Transfer Agent

Equiniti Trust Company, LLC
Toll Free in the US +1 800 937 5449
Foreign Shareowners: 718 921 8124
Email address: helpAST@equiniti.com
Website: https://equiniti.com